Scott Tarriff, CEO: Eagle Pharmaceuticals EGRX Sell · Filed 23/05/18

Trade details

Type: Insider sale
Amount: $299,700
Shares · price: 15,000 sh · $19.98 a share
Held after: 587,311 sh
Stock: Eagle Pharmaceuticals EGRX
Person: Scott TarriffCEO
Trade date: 23/05/16
Filed: 23/05/18
Days to filing: 2 days

Sold 2.5% of holdings

Share of holding sold: 2.5%

Eagle Pharmaceuticals trades, last 26 weeks

What else happened in Eagle Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/04/16~23/06/15

Scott Tarriff's recent trades

Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$151K
10,925 sh
$151K
Filed 23/11/03
Traded 23/11/01
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$148.3K
10,694 sh
$148.3K
Filed 23/11/03
Traded 23/11/02
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$144.9K
9,511 sh
$144.9K
Filed 23/10/04
Traded 23/10/02
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$144.4K
10,024 sh
$144.4K
Filed 23/10/04
Traded 23/10/03
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$10.7K
710 sh
$10.7K
Filed 23/10/04
Traded 23/10/03

Scott Tarriff, CEO — sold $299.7K of Eagle Pharmaceuticals EGRX · 2.5% of holdings | Whalegun